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Edited by Peter Tontonoz and Laszlo NagyAbstract The prevalence of obesity in the western world has
focused attention on factors that inﬂuence triglyceride biosynthe-
sis, storage, and utilization. Members of the lipin protein family
have a newly discovered enzymatic role in triglyceride and
phospholipid biosynthesis as a phosphatidate phosphatase, and
also act as an inducible transcriptional coactivator in conjunction
with peroxisome proliferator-activated receptor c (PPARc)
coactivator-1a and PPARa. Through these activities, the found-
ing member of the family, lipin-1, inﬂuences lipid metabolism
and glucose homeostasis in diverse tissues including adipose
tissue, skeletal muscle, and liver. The physiological roles of
lipin-2 and lipin-3 are less well deﬁned, but are likely to carry
out similar functions in glycerolipid biosynthesis and gene
expression in a distinct tissue distribution.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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It is now well established that adipose tissue plays a central
role in metabolic homeostasis. Both excessive and inadequate
adipose tissue mass are associated with conditions such as
insulin resistance, diabetes, hyperlipidemia, and premature
coronary artery disease [1–3]. The common thread in obesity
and adipose-deﬁcient conditions such as lipodystrophy is
impaired adipocyte function. Adipocytes are the source of
secreted factors such as leptin and adiponectin, which haveAbbreviations: PPARc, peroxisome proliferator-activated receptor c;
C/EBPa, CAAT enhancer binding protein-a; N-LIP, amino-terminal
lipin domain; C-LIP, carboxy-terminal lipin domain; PGC-1a, PPARc
coactivator-1a; PAP1, phosphatidate phosphatase-1; TAG, triacyl-
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doi:10.1016/j.febslet.2007.11.014important roles in modulating metabolism in the brain and
peripheral tissues [4]. In particular, leptin acts in the hypothal-
amus to promote satiety, and in peripheral tissues to regulate
energy expenditure and hepatic glucose production. Adiponec-
tin increases glucose uptake in skeletal muscle, and also
reduces hepatic glucose production and inﬂammation. In obes-
ity and lipodystrophy, the levels and/or sensitivity to these and
other adipokines may be reduced, contributing to insulin resis-
tance. Lipodystrophy and obesity may also promote lipid
accumulation in skeletal muscle, liver, and pancreatic beta
cells, leading to impaired function of these tissues and
impaired metabolic homeostasis [5].
The association of adipose tissue with many of the condi-
tions underlying the metabolic syndrome has fueled the search
for factors that inﬂuence adipocyte diﬀerentiation and lipid
storage. Work performed in the last two decades has revealed
a complex network of factors that regulate adipocyte diﬀeren-
tiation through transcriptional and cell cycle control [6,7].
Likewise, biochemical and genetic studies have deﬁned many
of the key players in triacylglycerol (TAG) biosynthesis, stor-
age, and lipolysis in adipose tissue [8]. In this review, we focus
on the lipin family of proteins, which appear to have dual cel-
lular roles, serving as an enzyme required for TAG and
phospholipid biosynthesis, and as a transcriptional coactivator
in the regulation of lipid metabolism genes. Through these
activities, the lipin proteins, particularly lipin-1, appear to play
important roles in metabolic homeostasis in adipose tissue as
well as skeletal muscle, liver, and other cell types.2. The lipin protein family
The founding member of the lipin protein family, lipin-1 was
identiﬁed in 2001 by positional cloning of the mutant gene
underlying lipodystrophy in the fatty liver dystrophy (ﬂd)
mouse [9]. The ﬂd mouse is named for two key features of the
mutant phenotype – the presence of a fatty liver for the ﬁrst 2
weeks of the postnatal period, and the subsequent development
of a peripheral neuropathy characterized by poorly compacted
myelin sheaths, abnormal Schwann cells, and myelin break-
down [10,11]. The ﬂd mouse also lacks normal adipose tissue
depots throughout the body, including visceral and subcutane-
ous white adipose tissue, and interscapular brown adipose
tissue [12]. This phenotype is reminiscent of some forms of gen-
eralized lipodystrophy in humans, but diﬀers in two ways –
fatty liver is typically chronic in human lipodystrophies, whileblished by Elsevier B.V. All rights reserved.
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occurs only in a subset of human patients [1].
The ﬂd mouse is deﬁcient for lipin-1 due to a null mutation
in the Lpin1 gene [9]. A second mutant allele carrying a mis-
sense point mutation arose independently in the ﬂd2J mouse
strain. This mutation converts an evolutionarily conserved gly-
cine to arginine, and results in a similar phenotype to the null
mutation [9]. Lipin-1 is expressed at highest levels in white and
brown adipose tissue, skeletal muscle, and testis, and is also
detectable in liver, peripheral nerve, brain, kidney, and pancre-
atic beta cells [9,13–15]. Expression of lipin-1 in peripheral
nerve is apparent in both the endoneurium, in which Schwann
cells are the predominant cell type, and in the peri/epineurium,
which includes adipocytes [15]. These observations suggest that
the neuropathy observed in ﬂd mice is a result of local lipin-1
deﬁciency in the nerve.
In mammals, there are three members of the lipin gene fam-
ily, which encode four lipin protein isoforms (Fig. 1A). Two
lipin-1 protein isoforms are generated by alternative mRNA
splicing of the Lpin1 gene, giving rise to proteins with
predicted sizes of approximately 98 and 102 kDa [13,16].
Lipin-2 and lipin-3 were identiﬁed through sequence similarity
to lipin-1 (44–48% amino acid identity) [9]. The three mamma-
lian lipin genes diﬀer in their tissue expression patterns
(Fig. 1A), suggesting that they have unique physiological roles.
Thus, lipin-2 is most prominently expressed in liver and brain,
whereas lipin-3 is present at low levels in several tissues, nota-
bly small intestine and liver [17]. At present, little is known
about the physiological role of these two family members.
However, the human lipin-2 gene, LPIN2, was recently identi-
ﬁed as the mutant gene in Majeed syndrome, a disorder char-
acterized by congenital dyserythropoietic anemia, recurrent
fever, chronic recurrent ostoemyelitis, and cutaneous inﬂam-
mation [18]. Family-speciﬁc LPIN2 mutations were identiﬁed
in two unrelated Jordanian families with Majeed syndrome,
including an early termination mutation and a single amino
acid substitution [19]. The normal physiological role of lipin-
2 in tissues aﬀected in Majeed syndrome is unclear, but theFig. 1. The lipin protein family. (A) Four lipin protein isoforms are shown sch
bars and nuclear localization signal as a blue line. Lipin-1A and -1B are alter
encoding 33 amino acids included in the lipin-1B protein (dark gray rectangle
each protein is shown. Tissues with prominent mRNA expression levels and k
LPIN2 genes are listed. (B) Known functional motifs and disease mutatio
between family members and in lipin orthologs from all species. NLS,
lipodystrophy; P, serine residue 106, which is known to be phosphorylated
transcription factor interaction domain; S734L, mutation in LPIN2 that cauphenotype of individuals harboring these mutations suggest a
non-redundant role for lipin-2 function. Virtually nothing is
currently known about the physiological function of lipin-3.
Lipin gene orthologs are also conserved across a broad
range of non-mammalian species, suggesting a fundamental
biological role [9]. Fish and plants appear to have two lipin-re-
lated genes; nematodes, fruit ﬂies, plasmodium, and yeast each
have one lipin gene ortholog. Lipin proteins in nearly all spe-
cies possess nuclear localization signals and several putative
serine and threonine phosphorylation sites. In addition, ex-
tended regions at the amino- and carboxy-terminal ends of
the lipin proteins (the amino-terminal lipin (N-LIP) and car-
boxy-terminal lipin (C-LIP) domains) are highly conserved
among all lipin proteins and all organisms, suggesting an
important functional role for these domains (Fig. 1). Indeed,
the C-LIP domain contains the active site motifs for the enzy-
matic and transcriptional coactivator functions of lipin-1
(Fig. 1B; described in a later section).3. Lipin-1 is required for the development of mature adipocytes
Studies of lipin-1-deﬁcient mice and cells have shown that
lipin-1 is required for adipocyte diﬀerentiation. Diﬀerentiation
occurs through an ordered cascade of gene-expression changes
that convert preadipocytes to mature, lipid-loaded adipocytes
[6,7]. Gene-expression analysis in lipin-1-deﬁcient cells and adi-
pose tissue from ﬂdmice revealed a striking defect in the induc-
tion of the adipogenic transcription program. Lipin-1-deﬁcient
cells and tissues failed to induce expression of two key tran-
scription factors, peroxisome proliferator-activated receptor
c (PPARc) and CAAT enhancer binding protein-a (C/EBPa),
and their downstream target genes [20]. Instead, they expressed
high levels of preadipocyte factor-1, an inhibitor of adipogen-
esis. Complementation of lipin-1-deﬁcient preadipocytes with a
retroviral vector expressing PPARc partially rescued adipocyte
diﬀerentiation, suggesting that lipin-1 may be required up-
stream of PPARc expression [20]. Consistent with this possibil-ematically, with regions of highest amino acid identity shown as yellow
native mRNA splice forms of the Lpin1 gene, with an additional exon
). The number of amino acid residues for human and mouse versions of
nown diseases resulting from mutation in the mouse Lpin1 and human
ns in lipin proteins. N-LIP and C-LIP domains exhibit conservation
nuclear localization signal; G84R, mutation in Lpin1 that causes
in response to insulin; DXDXT, PAP1 enzyme active site; LXXIL,
ses Majeed syndrome.
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lipin-1 expression was induced at two time points. Lipin-1 was
ﬁrst expressed transiently between 10 and 20 h after induction
of diﬀerentiation – before PPARc is expressed. After returning
to baseline levels, lipin-1 expression was induced again at 2
days after induction, and reached peak levels in mature,
lipid-loaded adipocytes. This biphasic pattern suggests that
lipin-1 has a role in establishing the adipogenic gene-expres-
sion program early during diﬀerentiation, and a later role in
bringing about the mature adipocyte phenotype. These two
roles may be related to the dual molecular functions of lipin,
described in a later section.
In addition to the biphasic expression of lipin-1 in diﬀeren-
tiating adipocytes, further complexity is conferred by the
expression of the lipin-1A and lipin-1B protein isoforms from
Lpin1. The isoforms appear to serve distinct functions in
adipocytes, with unique expression dynamics, subcellular
localization, and eﬀects on gene expression [16]. As adipocyte
diﬀerentiation progresses, lipin-1A levels diminish and lipin-
1B levels increase. As a result, lipin-1B is the predominant
form in mature adipocytes. Both isoforms can localize to the
cytoplasm or to the nucleus; however, in mature adipocytes,
lipin-1A is found predominantly in the nucleus, whereas
lipin-1B tends to be cytoplasmic.
Lipin-1A and lipin-1B also have distinct eﬀects on adipocyte
gene expression. When retroviral expression vectors were used
to complement lipin-1-deﬁcient mouse embryonic ﬁbroblasts,
expression of lipin-1A led to the induction of adipogenic genes,
such as PPARc and C/EBPa [16]. In contrast, lipin-1B induced
lipogenic genes, such as fatty acid synthase, stearoyl CoA
desaturase-1, and diacylglycerol acyltransferase (DGAT). Li-
pin-1A also induced lipogenic genes, but to a lesser degree.
Thus, the two isoforms appear to play complementary roles
during the conversion of preadipocytes to mature, lipid-ﬁlled
adipocytes.4. Enhanced lipin-1 expression in transgenic mice causes obesity
While lipin-1 deﬁciency produces lipodystrophy, enhanced
lipin-1 expression in transgenic mice promotes obesity. Lipin-
1 constructs driven by adipocyte fatty acid binding protein
(aP2) regulatory elements or muscle creatine kinase regulatory
elements were used to produce transgenic mice with elevated
lipin-1 expression in adipose tissue or skeletal muscle, respec-
tively [21]. On a high-fat diet, both types of transgenic mice
gained weight much faster than non-transgenic mice, despite
equivalent food intake. However, the mechanism for the obes-
ity and the eﬀects on glucose homeostasis diﬀered depending on
whether expression was enhanced in adipose tissue or muscle.
The adipose-speciﬁc lipin-1 transgenic mice had a normal
number of adipocytes, but increased fat cell triglyceride con-
tent and increased expression of lipogenic genes, including
fatty acid synthase, acetyl-CoA carboxylase, and DGAT
[16,21]. Unexpectedly, despite their higher body weight and
fat content, these mice had lower glucose and insulin levels
than non-transgenic mice, on both chow and high-fat diets.
Although the mechanism is not known, one possibility is that
more eﬃcient fatty acid trapping in adipose tissue may reduce
lipid deposition and compromised insulin action in muscle,
liver, and other tissues.The muscle-speciﬁc lipin-1 transgenic mice gained even more
weight than adipose-speciﬁc transgenic mice. These mice
became obese on a chow diet, and weight gain was accelerated
further on a high-fat diet. After only 6 weeks on the diet, the
muscle-speciﬁc transgenic mice had a 70% increase in body
weight; the increase in non-transgenic mice was only 20%
[21]. These transgenic mice had normal food intake, but a
15% reduction in energy expenditure and reduced fatty acid
oxidation in muscle. Moreover, unlike adipose-speciﬁc lipin-1
transgenic mice, they developed insulin resistance, presumably
due, in part, to increased triglyceride accumulation and altered
metabolism in muscle. Other studies have also implicated lipin-
1 in muscle metabolism. For example, lipin-1 expression in
muscle is increased in conditions that cause muscle atrophy
(e.g., diabetes, cachexia, uremia, and prolonged fasting) [22].5. Lipin-1 levels in adipose tissue correlate with insulin sensitivity
and reduced inﬂammatory cytokine expression in humans
The positive relationship between adipose tissue lipin-1 lev-
els and insulin sensitivity that was originally observed in the
aP2 transgenic mouse has been conﬁrmed in two studies in
humans. In a group of Finnish subjects, lipin-1 mRNA levels
in adipose tissue were inversely correlated with glucose, insu-
lin, and insulin resistance as measured by the homeostatic
model assessment of insulin resistance index [23]. Furthermore,
these studies demonstrated that speciﬁc polymorphisms in the
LPIN1 gene are associated with insulin levels and body mass
index in dyslipidemic Finnish families and in a case-control
sample of lean and obese individuals [23]. In a study of Amer-
ican subjects, insulin sensitivity measured with a frequently
sampled glucose tolerance test conﬁrmed that lipin-1 expres-
sion levels in adipose tissue are inversely correlated with insu-
lin resistance [24]. Thus, high adipose tissue lipin-1 mRNA
expression levels are associated with improved insulin sensitiv-
ity across species. In addition, allelic variants of Lpin1 inﬂu-
ence insulin levels and body mass index. However, unlike the
studies in transgenic mice, studies in humans have not revealed
a positive correlation between lipin-1 mRNA levels and body
mass, perhaps because the eﬀect is masked by other genetic
or environmental factors, or the endogenous gene is subject
to regulation that does not occur with the transgene.
Although the mechanism by which increased lipin-1 expres-
sion in adipose tissue leads to enhanced insulin sensitivity is
not well understood, lipin-1 expression levels in cultured
human adipocytes leads to enhanced expression of glucose
transporter 4 (GLUT4) and increased adipocyte glucose
uptake [25]. Interestingly, lipin-1 expression levels in human
adipose tissue and in cultured adipocytes increase in response
to treatment with thiazolidinedione drugs [24]. These results
raise the possibility that enhanced lipin-1 levels are one eﬀector
of the insulin-sensitizing eﬀects and/or increased adiposity
associated with TZD treatment. Lipin-1 expression in adipose
tissue is also enhanced by treatment with harmine, newly dis-
covered to increase insulin sensitivity in vitro and in vivo [26].
Although no LPIN1 mutations have thus far been identiﬁed
in congenital human lipodystrophy, lipin-1 expression levels
have been assessed in adipose tissue from patients with HIV-
associated lipodystrophy [27]. In HIV patients, but not control
subjects, lipin-1 mRNA levels in adipose tissue were positively
correlated with limb fat mass, and lipin-1 expression levels
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pin-1 mRNA levels were also inversely correlated with adipose
tissue expression of inﬂammatory cytokines that increase in
HIV-lipodystrophy, such as interleukin (IL)-6, IL-8, and IL-
18. Thus, maintenance of higher lipin-1 levels in adipose tissue
is associated with increased fat mass and reduced cytokine
expression in HIV-associated lipodystrophy, and may there-
fore inﬂuence the overall metabolic status.6. Lipin-1 is required for normal metabolic ﬂux between adipose
tissue and liver
Many conditions with compromised adipose tissue func-
tion, including lipodystrophy and obesity, are characterized
by increased hepatic fat storage leading to chronic fatty liver.
The lipin-1-deﬁcient ﬂd mouse is an exception in this regard,
as the adult mice have lipodystrophy without fatty liver. The
characterization of metabolism in the adipose tissue, liver and
skeletal muscle of ﬂd mice has shed some light on the possible
mechanism, and revealed a role for lipin-1 in the coordination
of peripheral glucose and fatty acid storage and utilization
throughout the diurnal cycle [28]. As determined by indirect
calorimetry and studies with stable-isotope-labeled substrates,
the ﬂd mouse was found to have an unusual adaptation to
the lack of adipose tissue stores. During the fed state, ﬂd mice
store twofold greater amounts of glycogen in liver and mus-
cle, and utilize these reserves in place of fat during the fasted
state. During the feeding period, fatty acid biosynthesis is en-
hanced in the ﬂd liver to provide energy substrates to periph-
eral tissues, thus sparing glucose for storage. These ﬁndings
explain how ﬂd mice survive fasting without triglyceride stor-
age in their adipose tissue and why triglycerides do not accu-
mulate in the liver. They also suggest that lipin-1 may
normally play a role in directing nutrients toward energy
storage or utilization. This is consistent with the observationFig. 2. Dual cellular functions of lipin proteins. Lipin-1, -2, and -3 all exhibi
and phospholipid biosynthesis. Lipin-1 has also been shown to act as a transc
such as PPARa and the coactivator PGC-1a.that lipin-1 is a downstream target of the mammalian target
of rapamycin (mTOR), which functions at the interface be-
tween nutrient sensing and regulation of metabolic responses
[13].7. Lipins function as phosphatidate phosphatase enzymes in
TAG and phospholipid biosynthesis
Studies described above have revealed important physiolog-
ical roles for lipin-1 in metabolic homeostasis, but the cellular
function of lipin proteins had remained mysterious until re-
cently, when two distinct functions have been identiﬁed. The
ﬁrst is serving as an enzyme in TAG and phospholipid biosyn-
thesis; the second is acting as a transcriptional coactivator that
regulates expression of fatty acid utilization and lipid synthetic
genes (Fig. 2). These two functions are described in the follow-
ing two sections.
In most mammalian cell types, including adipocytes, TAG is
synthesized via the glycerol phosphate pathway. Acylation of
glycerol phosphate occurs through a step-wise addition of acyl
groups, each addition catalyzed by a distinct enzyme (Fig. 2)
[8]. The enzymes catalyzing most steps in TAG biosynthesis
had been identiﬁed, but the molecular identity of phosphati-
date phosphatase-1 (PAP1), which catalyzes the conversion
of phosphatidate to diacylglycerol (DAG), was unknown until
recently. DAG is the precursor for both TAG, through the ac-
tion of DGAT enzymes, and for neutral phospholipids, phos-
phatidylcholine and phosphatidylethanolamine [29].
Carman’s group puriﬁed PAP1 activity from Saccharomyces
cerevisiae and through amino acid sequencing, identiﬁed it as
Smp2p, the yeast ortholog of lipin [30]. The 3 mammalian lipin
proteins were subsequently demonstrated to act as Mg2+-
dependent PAP1 enzymes, and to contain the DxDxT catalytic
motif in the C-LIP domain (Fig. 1B), which is conserved from
mammals to yeast [17,31,32]. The presence of the DxDxT mo-t phosphatidate phosphatase activity, which plays a role in triglyceride
riptional coactivator in liver, directly interacting with nuclear receptors
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ase (HAD)-like superfamily [33,34]. In the DxDxT catalytic
motif, the ﬁrst aspartate residue acts as a nucleophile that
forms an aspartyl-intermediate during catalysis. The second
acidic residue binds and protonates the substrate leaving group
in the ﬁrst step, and deptotonates the nucleophile of the second
step. The Mg2+ cofactor is coordinated by the carboxylate
group of the ﬁrst aspartate and the backbone of the second
aspartate. Consistent with the requirement of the aspartate res-
idues for catalytic activity, mutation of the ﬁrst aspartate
within the DxDxT motif (D712E) abolishes PAP1 activity of
lipin-1 [31].
Using tissues from ﬂdmice, it was determined that lipin-1 ac-
counts for all PAP1 activity in white and brown adipose tissue,
and skeletal muscle, the metabolic tissues with the highest
levels of lipin-1 expression [17]. This is consistent with the im-
paired TAG accumulation in adipose tissue of ﬂd mice, as well
as the increased TAG accumulation in adipocytes of lipin-1
adipose-speciﬁc transgenic mice [12,21]. PAP1 activity was also
absent in heart, lung, and kidney of ﬂd mice [32]. Activity in
liver of ﬂd mice, however, was normal [17] or reduced by
50% [32], suggesting that perhaps another member(s) of the
lipin protein family compensate. Consistent with these possi-
bilities, lipin-2 is normally expressed at substantial levels in
liver of wild-type and ﬂd mice, and lipin-3 is upregulated in
the liver of ﬂd mice [17].
Expression of each of the lipin protein family members
(lipin-1A, lipin-1B, lipin-2, and lipin-3) in cultured cells re-
vealed that every member has PAP1 activity, and that activity
is speciﬁc for phosphatidate, having no activity against other
lipid phosphates including lysophosphatidic acid, ceramide-1-
phosphate, or sphingosine-1-phosphate [17]. A comparison
of lipin-1A and lipin-1B revealed approximately 70% higher
PAP1 speciﬁc activity and higher Vmax for the longer isoform,
lipin-1B [17]. Since the 33 amino acids that are unique to lipin-
1B are spatially distant from the DxDxT catalytic motif, the
activity diﬀerence is apparently related to other structural dif-
ferences between the two isoforms. The Vmax for lipin-2 was
similar to that of lipin-1A, while lipin-3 was somewhat lower.
All three family members exhibited strong positive cooperativ-
ity for phosphatidate, suggesting that the lipins function as
dimers or higher-order oligomers [17].
As described above, the DAG that results from PAP1 action
is a substrate for phospholipid as well as TAG biosynthesis. To
date, little work has directly assessed the physiological role of
mammalian lipin proteins in phospholipid biosynthesis. How-
ever, elegant studies in yeast have shown that Smp2 regulates
nuclear membrane growth during the cell cycle by controlling
phospholipid biosynthesis [35]. Smp2-deﬁcient cells undergo a
massive expansion of the nuclear envelope, due to transcrip-
tional upregulation of phospholipid biosynthetic gene expres-
sion. The resulting nuclear membrane extensions observed in
Smp2-deﬁcient yeast are reminiscent of membrane whorls ob-
served in brown adipose tissue and liver of lipin-1-deﬁcient ﬂd
mice [12]. Interestingly, recent studies have implicated lipin-1
in the increased phospholipid synthesis for endoplasmic retic-
ulum membrane expansion that occurs as B lymphocytes dif-
ferentiate into antibody-secreting plasma cells [36]. These
studies raise the possibility that lipin-1, and potentially other
lipin protein family members, have roles in additional condi-
tions that involve membrane expansion.8. Lipin-1 is an inducible transcriptional coactivator
As described above, lipin-1 is present both in the cytoplasm
and in the nucleus of mammalian cells. Studies in both bud-
ding and ﬁssion yeast also suggest that lipin-1 has a speciﬁc
function in the nucleus. Thus, mutation of Ned1, the lipin
ortholog in ﬁssion yeast, causes aberrant nuclear shape and
chromosome missegregation [37]. Ned1p also interacts with
three nuclear proteins involved in the Ran GTPase cycle,
which regulates nuclear envelope formation and directional
nuclear transport. These interactions occur through the evolu-
tionarily conserved N-LIP domain of Ned1p, suggesting that
similar interactions might occur in mammalian lipin proteins.
Furthermore, the regulation of phospholipid biosynthesis by
Smp2 described above occurs through Smp2 interactions with
promoters of phospholipid biosynthetic genes, suggesting a di-
rect role in regulation of gene transcription [35].
Mammalian lipins may also have a role in regulation of gene
expression. Recently, Finck et al. [31] showed that mammalian
lipin-1 has transcriptional coactivator activity. In studies of
PPARc coactivator-1a (PGC-1a) knockout mice, these investi-
gators uncovered a role for lipin-1 in activation of fatty acid
oxidation genes during fasting. This occurs through direct
interaction of lipin-1 with PGC-1a and PPARa, leading to
the formation of a complex that modulates gene transcription.
This interaction occurs through an a-helical leucine-rich motif
(LxxIL) in the C-LIP domain of lipin-1 (Fig. 1B). Enhanced
lipin-1 expression in hepatocytes ampliﬁed the expression of
PGC-1a/PPARa target genes involved in fatty acid oxidation
(e.g., acyl CoA oxidase, PPARa, carnitine palmitoyl transfer-
ase-1, medium and very long chain acyl CoA dehydrogenases),
and suppressed expression of genes involved in de novo lipo-
genesis (e.g., sterol response element binding protein-1, fatty
acid synthase, and stearoyl CoA desaturase) [31]. In addition
to PPARa, lipin-1 was shown to interact with HNF4a,
PPARb, PPARc, and the glucocorticoid receptor [31]. And
although lipin-1 lacks a DNA binding domain, chromatin
immunoprecipitation assays revealed interaction of lipin-1
containing complexes with the PPARa gene promoter, analo-
gous to the interaction of Smp2 with phospholipid synthesis
gene promoters in yeast [31,35]. Both lipin-2 and lipin-3 pos-
sess the LxxIL motif that mediates interaction with nuclear
receptors, and initial studies suggest that lipin-3 can physically
interact with PPARa [31]. The physiological role of the tran-
scriptional coactivator function of lipin family members in tis-
sues other than liver remains to be determined.9. Regulation of lipin-1 transcription, phosphorylation, and
activity
It appears that regulation of lipin-1 activity is complex,
occurring at the levels of mRNA transcription, mRNA splic-
ing, protein phosphorylation, and subcellular localization.
The regulation of PAP1 activity has been studied for more
than 25 years, prior to the identiﬁcation of lipin proteins. Un-
like most TAG biosynthetic enzymes, which reside in the ER
or mitochondria, PAP1 is primarily cytosolic and translocates
to the ER membrane in response to fatty acids or acyl-CoAs
[38]. In liver, PAP1 activity is increased in diabetes, hypoxia,
and toxic fatty liver and in response to elevated glucocorticoids
Fig. 3. Physiological roles of lipin-1. Lipin-1, and potentially other
members of the lipin protein family, have important functions in lipid
and energy homeostasis in adipose tissue, skeletal muscle, liver and
other tissues.
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starvation and diabetes, reﬂecting decreased TAG synthesis
and increased lipolysis [40]. Thus, there appear to be important
diﬀerences in the regulation of PAP1 activity in speciﬁc tissues.
The identiﬁcation of lipin-1 as PAP1 has allowed initial stud-
ies of its regulation at the transcriptional and post-transcrip-
tional levels. It has been known for several years that PAP1
is regulated by phosphorylation [38], and there have now been
multiple sites identiﬁed on the lipin-1 protein that are phos-
phorylated in response to insulin [13,32]. Three of the phos-
phorylation sites identiﬁed in lipin-1 (Ser106, Ser634, and
Ser720) are conserved in all three lipin family members, and
in the yeast lipin ortholog. Ser106 appears to be a major site
of insulin-stimulated phosphorylation, and this phosphoryla-
tion is dependent on the mTOR pathway, as demonstrated
by rapamycin inhibition [13,32]. In contrast to insulin, epi-
nephrine and oleic acid both lead to lipin-1 dephosphorylation
[32]. Importantly, phosphorylation of lipin-1 does not appear
to directly aﬀect PAP1 activity, but rather to mediate the
cytopasmic vs. microsomal localization, with the ratio of solu-
ble to microsomal lipin-1 increased by phosphorylation. In the
yeast, the enzymes responsible for Smp2 phosphorylation
(Cdc28/Cdk1) and dephosphorylation (Nem1/Spo7) have been
identiﬁed [35].
As described earlier, lipin-1 mRNA expression is regulated
during adipocyte diﬀerentiation [16,20], and in liver during
fasting and in type 1 and type 2 diabetes mellitus [31]. Hepatic
lipin-1 is also regulated by dietary fatty acids, with a 400-fold
increase in mRNA observed in response to a low fat diet con-
taining saturated vs. polyunsaturated fats [41]. The regulation
of lipin-1 by fatty acids appears to be mediated by PPARa, as
it did not occur in PPARa deﬁcient mice. In the mouse, lipin-1
gene expression is also under circadian regulation, with a strik-
ing peak in both liver and adipose tissue during the daytime
[42], in agreement with the observed increase during fasting.
The circadian regulation of lipin-1 in peripheral tissues may
be under the control of endogenous glucocorticoids, as the cir-
cadian cycling of lipin-1 was abolished in adrenalectomized
mice [43]. At present it is known that alternative splicing of li-
pin-1 mRNA is regulated by changes that occur during adipo-
cyte diﬀerentiation [16], but the mechanism is not known.10. Summary and future perspectives
Studies of the lipin protein family thus far have largely
focused on the founding member of the family, lipin-1. Studies
in mouse models and humans indicate an important physiolog-
ical role for lipin-1 in tissues that function in lipid metabolism
(adipose tissue, skeletal muscle, and liver) as well as other
specialized cell types (Fig. 3). Lipin-1 levels in adipose tissue
profoundly aﬀect fat mass in mouse models and correlate pos-
itively with insulin sensitivity in mice and humans. A key ad-
vance has been the recent discovery of dual cellular functions
of lipin-1 – PAP1 enzymatic activity and transcriptional coac-
tivator activity. Although uncommon, this dual enzymatic-
coactivator activity is not unique to lipin-1. Other metabolic
enzymes with demonstrated transcriptional coactivator activi-
ties include glyceraldehyde-3-phosphate dehydrogenase [44]
and O-GlcNac transferase [45]. Many exciting questions re-
main to be answered. How are the enzymatic and transcrip-
tional activities of lipin-1 coordinated in the cell and indiﬀerent tissue types? What are the physiological roles of li-
pin-2 and lipin-3? Lipin-2 and lipin-3 possess PAP1 activity;
do they also have second functions as transcriptional coactiva-
tors? An understanding of the function of lipin family mem-
bers may lead to novel approaches for modulating important
metabolic processes, such as triglyceride and phospholipid bio-
synthesis, and insulin sensitivity.
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